From: A property-based analysis of human transcription factors
Category* | Term | Observed | Expected | Pvalue | Benjamini | MCC |
---|---|---|---|---|---|---|
II + IIIAB | Acetylation | 48 | 26 | 1.823E-08 | 1.46E-07 | 0.125 |
Ubiquitination | 47 | 27 | 2.08E-07 | 8.31E-07 | 0.118 | |
Methylation | 26 | 11 | 1.21E-05 | 3.23E-05 | 0.110 | |
PF00856(SET) | 6 | 0 | 1.21E-05 | 8.80E-03 | 0.164 | |
PF13771(zf-HC5HC2H) | 4 | 0 | 4.90E-05 | 1.78E-02 | 0.175 | |
PF00628(PHD) | 8 | 1 | 1.78E-04 | 2.58E-02 | 0.114 | |
Sumoylation | 14 | 5 | 1.14E-03 | 2.28E-0 | 0.082 | |
O-GlcNAc | 5 | 1 | 7.03E-03 | 1.12E-02 | 0.078 | |
II | Acetylation | 21 | 12 | 1.67E-03 | 1.33E-02 | 0.073 |
Ubiquitination | 20 | 12 | 6.61E-03 | 2.64E-02 | 0.063 | |
Methylation | 11 | 5 | 1.23E-02 | 3.28E-02 | 0.062 | |
O-GlcNAc | 3 | 0 | 1.89E-02 | 3.78E-02 | 0.073 | |
IIIB | Sumoylation | 5 | 1 | 3.51E-03 | 2.80E-02 | 0.085 |
I + IIIAB | Ubiquitination | 32 | 16 | 2.69E-07 | 2.15E-06 | 0.114 |
Acetylation | 30 | 16 | 6.44E-06 | 2.12E-05 | 0.101 | |
Methylation | 19 | 7 | 7.94E-06 | 2.12E-05 | 0.114 | |
PF00856(SET) | 5 | 0 | 1.67E-05 | 5.78E-03 | 0.178 | |
PF00628(PHD) | 7 | 1 | 4.70E-05 | 8.56E-03 | 0.136 | |
PF13771(zf-HC5HC2H) | 3 | 0 | 3.17E-04 | 2.25E-02 | 0.168 | |
Sumoylation | 10 | 3 | 1.82E-03 | 3.64E-03 | 0.082 | |
DNA_Binding | 15 | 22 | 9.56E-03 | 1.53E-02 | −0.061 | |
IIIAB | Acetylation | 27 | 14 | 5.47E-06 | 2.56E-05 | 0.102 |
Ubiquitination | 27 | 14 | 6.39E-06 | 2.56E-05 | 0.101 | |
PF00628(PHD) | 6 | 0 | 1.82E-04 | 2.64E-02 | 0.125 | |
PF00439(Bromodomain) | 4 | 0 | 4.78E-04 | 4.35E-02 | 0.132 | |
Methylation | 15 | 6 | 2.79E-04 | 7.44E-04 | 0.091 | |
Sumoylation | 9 | 3 | 2.28E-03 | 4.56E-03 | 0.081 | |
DNA_Binding | 12 | 19 | 5.45E-03 | 8.71E-03 | −0.065 | |
I | Methylation | 4 | 0 | 5.47E-03 | 4.38E-02 | 0.078 |